| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.764 | 16.580 | 32.724 | 43.107 | 54.257 | 58.005 |
| Total Income - EUR | - | - | - | - | 2.764 | 16.580 | 32.724 | 43.107 | 54.257 | 58.005 |
| Total Expenses - EUR | - | - | - | - | 1.470 | 5.853 | 29.205 | 41.393 | 53.108 | 39.793 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.294 | 10.728 | 3.520 | 1.714 | 1.149 | 18.212 |
| Net Profit/Loss - EUR | - | - | - | - | 1.211 | 10.255 | 2.538 | 1.001 | 666 | 15.483 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Gambi Bioprod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.515 | 1.438 | 4.349 | 3.528 | 2.685 | 2.602 |
| Current Assets | - | - | - | - | 1.016 | 10.061 | 11.339 | 15.363 | 15.012 | 72.761 |
| Inventories | - | - | - | - | 2 | 31 | 1.044 | 1.047 | 1.423 | 4.803 |
| Receivables | - | - | - | - | 206 | 2.339 | 7.691 | 9.097 | 11.485 | 64.787 |
| Cash | - | - | - | - | 808 | 7.691 | 2.605 | 5.218 | 2.104 | 3.170 |
| Shareholders Funds | - | - | - | - | 556 | 10.800 | 13.099 | 14.141 | 14.764 | 30.165 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.974 | 699 | 2.589 | 4.750 | 2.933 | 45.198 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1039 - 1039" | |||||||||
| CAEN Financial Year |
1039
|
|||||||||
Comments - Gambi Bioprod S.r.l.